DILACOR XR Drug Patent Profile
✉ Email this page to a colleague
When do Dilacor Xr patents expire, and when can generic versions of Dilacor Xr launch?
Dilacor Xr is a drug marketed by Allergan and is included in one NDA.
The generic ingredient in DILACOR XR is diltiazem hydrochloride. There are twenty-six drug master file entries for this compound. Forty-nine suppliers are listed for this compound. Additional details are available on the diltiazem hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Dilacor Xr
A generic version of DILACOR XR was approved as diltiazem hydrochloride by TEVA on May 31st, 1995.
Summary for DILACOR XR
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 32 |
Clinical Trials: | 1 |
Patent Applications: | 72 |
Formulation / Manufacturing: | see details |
DailyMed Link: | DILACOR XR at DailyMed |
Recent Clinical Trials for DILACOR XR
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Assiut University | Early Phase 1 |
Anatomical Therapeutic Chemical (ATC) Classes for DILACOR XR
US Patents and Regulatory Information for DILACOR XR
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Allergan | DILACOR XR | diltiazem hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 020092-001 | May 29, 1992 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Allergan | DILACOR XR | diltiazem hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 020092-002 | May 29, 1992 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Allergan | DILACOR XR | diltiazem hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 020092-003 | May 29, 1992 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for DILACOR XR
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Allergan | DILACOR XR | diltiazem hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 020092-002 | May 29, 1992 | ⤷ Try a Trial | ⤷ Try a Trial |
Allergan | DILACOR XR | diltiazem hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 020092-002 | May 29, 1992 | ⤷ Try a Trial | ⤷ Try a Trial |
Allergan | DILACOR XR | diltiazem hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 020092-001 | May 29, 1992 | ⤷ Try a Trial | ⤷ Try a Trial |
Allergan | DILACOR XR | diltiazem hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 020092-003 | May 29, 1992 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for DILACOR XR
See the table below for patents covering DILACOR XR around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Italy | 8922694 | ⤷ Try a Trial | |
Japan | S62155211 | CONTROLLED SPEED RELEASE DEVICE FOR ACTIVE SUBSTANCE | ⤷ Try a Trial |
New Zealand | 218596 | SYSTEM FOR THE CONTROLLED RELEASE OF ACTIVE SUBSTANCES | ⤷ Try a Trial |
European Patent Office | 0432607 | Comprimés à libération contrÔlée des substances actives (Tablets with controlled-rate release of active substances) | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |